Sirtris Pharmaceuticals, Inc. 4/A
4/A · Sirtris Pharmaceuticals, Inc. · Filed Jan 22, 2008
Insider Transaction Report
Form 4/AAmended
Jirousek Michael
Senior VP, Research
Transactions
- Award
Incentive Stock Option (Right to buy)
2008-01-02+32,500→ 32,500 totalExercise: $13.00Exp: 2018-01-02→ Common Stock (32,500 underlying) - Award
Common Stock
2008-01-02+32,500→ 32,500 total
Footnotes (1)
- [F1]The options shall vest as to 25% on January 2, 2009, with the remainder to vest in equal quarterly installments over the next 12 quarters ending April 2, July 2, and October 2 following January 2, 2009.